Australian pre-clinical pharmaceutical company, Nyrada Inc. (ASX: NYR) is advancing well with its drug development objectives, to cater to the large, underserved therapeutic needs of its targeted patient groups. The newly-listed dr...
With an expected healthy cash runway until the end of 2021, Australian pharmaceutical company Nyrada Inc. (ASX: NYR) appears to be progressing well in its drug discovery and development program of its two lead programs in cholesterol-lowering and bra...
Australian drug discovery and development company Nyrada Inc. (ASX: NYR) which listed in January, reports solid progress in advancing its two lead R&D programs, one a treatment for brain injury and the other a novel cholesterol loweri...
US-registered Nyrada Inc is a biopharmaceutical company focussed on discovery and early phase drug development. It listed on the Australian Securities Exchange on 16 January 2020 (ASX: NYR) and the IPO offer was fully subscribed, raising A$8.5 millio...
Get a call to receive stock recommendation services from Kalkine Pty Ltd (www.kalkine.com.au)
